Medifast Inc. (MED)
NYSE: MED
· Real-Time Price · USD
13.55
-0.30 (-2.17%)
At close: Sep 05, 2025, 3:59 PM
13.55
0.00%
After-hours: Sep 05, 2025, 06:09 PM EDT
Medifast Revenue Breakdown
| Period Ending | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Weight Control Centers Revenue | 2.59M | 2.76M | 3.38M | 3.46M | 3.62M | 3.69M | 4.11M | 4.25M | 3.72M | 4.01M | 4.67M | 4.68M |
| Franchise Weight Control Centers Revenue Growth | -6.12% | -18.21% | -2.31% | -4.53% | -1.90% | -10.15% | -3.25% | +14.04% | -7.16% | -14.15% | -0.19% | n/a |
| Medifast Direct Revenue | 6.59M | 7.79M | 8.57M | 8.95M | 6.79M | 8.1M | 9.32M | 10.93M | 9.27M | 11.27M | 13.68M | 14.43M |
| Medifast Direct Revenue Growth | -15.40% | -9.20% | -4.17% | +31.80% | -16.23% | -13.08% | -14.67% | +17.87% | -17.75% | -17.58% | -5.21% | n/a |
| Medifast Wholesale Physicans Revenue | 218K | 222K | 230K | 261K | 248K | 273K | 300K | 497K | 343K | 771K | 1.56M | 2.15M |
| Medifast Wholesale Physicans Revenue Growth | -1.80% | -3.48% | -11.88% | +5.24% | -9.16% | -9.00% | -39.64% | +44.90% | -55.51% | -50.45% | -27.80% | n/a |
| Optavia Revenue | 68.61M | 66.43M | 63.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Optavia Revenue Growth | +3.27% | +4.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 77.71M | 84.51M | 86.21M | 102.47M | 130.21M | 118.35M | 132.69M | 151.87M | 172.01M | 192.88M | 201M | 234.69M | 272.72M | 247.2M | 231.45M | 251.89M | 232.27M | 195.75M | 161.27M | 159.48M | 131.2M | 111.71M | 109.36M | 122.67M | 113.36M | 100.43M | 89.29M | 89.73M | 71.69M | 60.13M | 49.64M | 47.96M | 46.3M | 44.28M | 40.47M | 43.21M | 48.2M | 46.93M | 39.68M | 41.19M | 44.5M | 47.26M |
| Selling, General, and Administrative Revenue Growth | -8.04% | -1.98% | -15.87% | -21.31% | +10.02% | -10.81% | -12.63% | -11.71% | -10.82% | -4.04% | -14.36% | -13.94% | +10.32% | +6.80% | -8.11% | +8.44% | +18.66% | +21.38% | +1.12% | +21.55% | +17.45% | +2.15% | -10.85% | +8.22% | +12.87% | +12.48% | -0.50% | +25.17% | +19.23% | +21.12% | +3.51% | +3.57% | +4.56% | +9.43% | -6.35% | -10.35% | +2.72% | +18.25% | -3.64% | -7.46% | -5.83% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 1.1M | 1M | 1.2M | 1.3M | 1.1M | 1M | 1.2M | 1.1M | 1.2M | 900K | 1.1M | 1.2M | 1.1M | 1M | 900K | 800K | 500K | 500K | 900K | 600K | 500K | 700K | 600K | 621K | 561K | 421K | 400K | 343K | 359K | 385K | 500K | 311K | 543K | 312K | 1.8M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | +10.00% | -16.67% | -7.69% | +18.18% | +10.00% | -16.67% | +9.09% | -8.33% | +33.33% | -18.18% | -8.33% | +9.09% | +10.00% | +11.11% | +12.50% | +60.00% | 0.00% | -44.44% | +50.00% | +20.00% | -28.57% | +16.67% | -3.38% | +10.70% | +33.25% | +5.25% | +16.62% | -4.46% | -6.75% | -23.00% | +60.77% | -42.73% | +74.04% | -82.67% | n/a | n/a | n/a | n/a |